Form4insider filings, from the source

SEC Form 4/A · accession 0000899243-18-000527

Cardiff Oncology, Inc. · CRDF

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Mark Erlander
Officer — Chief Scientific Officer
Period of report
Jan 2, 2018
Accepted (ET)
Jan 4, 2018 · 8:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001213037

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 2, 2018M18,750$0.00A66,855D
Common StockF2Jan 2, 2018F9,558$0.00D57,297D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF3,F4—Jan 2, 2018M18,750D——Common Stock18,750146,250D

Explanation of responses